552 Evaluation of the pharmacokinetic (PK) interactions between cetuximab and irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing advanced solid tumors. Results of a phase I study
暂无分享,去创建一个
E. Raymond | J. Pierga | S. Faivre | V. Diéras | A. Kovar | C. Delbaldo | M. Bonnay | A. Nolting | J. Vedovato | M. Mueser